Abrams Capital Management - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 222 filers reported holding TRANSMEDICS GROUP INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Abrams Capital Management ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q4 2020$69,647,000
+44.4%
3,499,8590.0%1.96%
+28.9%
Q3 2020$48,228,000
-23.1%
3,499,8590.0%1.52%
-24.8%
Q2 2020$62,717,000
+48.3%
3,499,8590.0%2.03%
+21.8%
Q1 2020$42,278,000
-36.5%
3,499,8590.0%1.66%
-19.5%
Q4 2019$66,532,000
-17.3%
3,499,8590.0%2.07%
-8.2%
Q3 2019$80,443,000
-8.4%
3,499,8590.0%2.25%
-5.6%
Q2 2019$87,820,0003,499,8592.38%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q3 2023
NameSharesValueWeighting ↓
Must Asset Management Inc. 94,202$5,168,86312.65%
Eagle Health Investments LP 414,205$22,677,7245.00%
Ophir Asset Management Pty Ltd 295,761$16,192,9153.82%
Sandhill Capital Partners LLC 732,610$40,110,4093.75%
First Light Asset Management, LLC 618,100$33,840,9753.21%
NEXT CENTURY GROWTH INVESTORS LLC 477,482$26,142,1392.84%
Bullseye Asset Management LLC 70,512$3,8612.15%
Kent Lake Capital LLC 100,000$5,475,0002.10%
Nicholas Investment Partners, LP 413,714$22,650,8421.69%
AtonRa Partners 12,287$672,7131.41%
View complete list of TRANSMEDICS GROUP INC shareholders